Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques
Science · 08.03.2024 · 383 (6687) · 1104-1111
DOI: 10.1126/science.adf7966 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 08.03.2024. Verfasst von So-Yon Lim und 26 weiteren Autor:innen. Beteiligte Einrichtung: Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. Hauptthemen laut MEDLINE: Anti-Retroviral Agents, Simian Acquired Immunodeficiency Syndrome, Simian Immunodeficiency Virus, Recombinant Fusion Proteins. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
The eradication of the viral reservoir represents the major obstacle to the development of a clinical cure for established HIV-1 infection. Here, we demonstrate that the administration of N-803 (brand name Anktiva) and broadly neutralizing antibodies (bNAbs) results in sustained viral control after discontinuation of antiretroviral therapy (ART) in simian-human AD8 (SHIV-AD8)–infected, ART-suppressed rhesus macaques. N-803+bNAbs treatment induced immune activation and transient viremia but only limited reductions in the SHIV reservoir. Upon ART discontinuation, viral rebound occurred in all animals, which was followed by durable control in approximately 70% of all N-803+bNAb–treated macaques. Viral control was correlated with the reprogramming of CD8 + T cells by N-803+bNAb synergy. Thus, complete eradication of the replication-competent viral reservoir is likely not a prerequisite for the induction of sustained remission after discontinuation of ART.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Altor Biosciences, Miramar, FL 33027, USA.
- Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
ORCID-Profile: So-Yon Lim, Jina Lee, Christa E Osuna, Pratik Vikhe, Dane R Schalk, Emily Fray, Mithra Kumar, Nancy Schultz-Darken, Eva Rakasz, Ruby A Ladd, Hwi Min Gil, David T Evans, Michael Seaman, Malcolm Martin, Christiaan Van Dorp, Alan S Perelson, Janet D Siliciano, Robert Siliciano, Douglas F Nixon, Patrick Soon-Shiong, Michel Nussenzweig, James B Whitney
Förderung
- NIH HHS
- NIAID NIH HHS
Zitieren
APA
Lim, S. Y., Lee, J., Osuna, C. E., Vikhe, P., Schalk, D. R., Chen, E., Fray, E., Kumar, M., Schultz-Darken, N., Rakasz, E., Capuano, S., Ladd, R. A., Gil, H. M., Evans, D. T., Jeng, E. K., Seaman, M., Martin, M., Van Dorp, C., Perelson, A. S., …, & Whitney, J. B. (2024). Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques. Science, 383(6687), 1104-1111. https://doi.org/10.1126/science.adf7966
Vancouver
Lim SY, Lee J, Osuna CE, Vikhe P, Schalk DR, Chen E, et al. Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques. Science. 2024;383(6687):1104-1111. doi:10.1126/science.adf7966
BibTeX
@article{Lim2024,
author = {Lim, So-Yon and Lee, Jina and Osuna, Christa E and Vikhe, Pratik and Schalk, Dane R and Chen, Elsa and Fray, Emily and Kumar, Mithra and Schultz-Darken, Nancy and Rakasz, Eva and Capuano, Saverio and Ladd, Ruby A and Gil, Hwi Min and Evans, David T and Jeng, Emily K and Seaman, Michael and Martin, Malcolm and Van Dorp, Christiaan and Perelson, Alan S and Wong, Hing C and Siliciano, Janet D and Siliciano, Robert and Safrit, Jeffrey T and Nixon, Douglas F and Soon-Shiong, Patrick and Nussenzweig, Michel and Whitney, James B},
title = {Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques},
journal = {Science},
year = {2024},
volume = {383},
number = {6687},
pages = {1104--1111},
doi = {10.1126/science.adf7966}
}
EUVIMED